# Safety and Exploratory Efficacy Study of UCMSCs in Patients With Ischemic Heart Disease (SEESUPIHD)

> **NCT02666391** · PHASE1,PHASE2 · UNKNOWN · sponsor: **South China Research Center for Stem Cell and Regenerative Medicine** · enrollment: 64 (estimated)

## Conditions studied

- Acute Myocardial Infarction
- Myocardial Infarction
- Ischemic Cardiomyopathy

## Interventions

- **BIOLOGICAL:** umbilical cord mesenchymal stem cells

## Key facts

- **NCT ID:** NCT02666391
- **Lead sponsor:** South China Research Center for Stem Cell and Regenerative Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-05
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2016-01-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02666391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02666391, "Safety and Exploratory Efficacy Study of UCMSCs in Patients With Ischemic Heart Disease (SEESUPIHD)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02666391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*